II International Symposium: AMR and Beyond
Pulmonary antibody mediated rejection (AMR) after lung transplantation is an important cause of acute and chronic allograft dysfunction. Understanding the clinical, pathological and immunological features of AMR will help to close the practice gap in specialist knowledge. We are delighted to offer for the second time this interactive educational opportunity to update the knowledge in this complex diagnostic scenario.
IV International Conference On: End Stage Lung Diseases (ESLD)
Based on the success of the previous editions, the scientific organizing committee is excited to launch its 4th theme-based scientific conference.
The ESLDs focus on progressive lung diseases potentially requiring lung transplantation and this year the main theme will be Cystic Fibrosis (CF). The efforts of all transplant specialists are directed towards the improvement of the very complex transplant management of these usually young patients. The novelty of this edition is not only a wide involvement of all the specialists (psychologists, endocrinologists, pneumologists, surgeons, pathologists, immunologists) who play a crucial role in the diagnostic/therapeutic process, but also the participation of patient and family associations.